Home › Graft-Versus-Host Disease › California › Los Angeles
Graft-Versus-Host Disease clinical trials in Los Angeles, CA
3 studies for Graft-Versus-Host Disease are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RecruitingPhase 2
- UCLA Department of Medicine, Los Angeles
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- University of Southern California Norris Comprehensive Cancer Center, Los Angeles
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Ronald Regan UCLA Medical Center, Los Angeles
Graft-Versus-Host Disease trials in other cities
- Boston, MA10 studies
- New York City, NY7 studies
- Columbus, OH6 studies
- Baldwin Park, CA5 studies
- Atlanta, GA5 studies
- Washington, DC5 studies
- Pittsburgh, PA4 studies
- St. Louis, MO4 studies
- Tampa, FL4 studies
- Portland, OR4 studies
- Detroit, MI4 studies
- Miami, FL4 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.